全文获取类型
收费全文 | 182081篇 |
免费 | 14972篇 |
国内免费 | 4918篇 |
专业分类
耳鼻咽喉 | 1568篇 |
儿科学 | 10536篇 |
妇产科学 | 4133篇 |
基础医学 | 17789篇 |
口腔科学 | 1812篇 |
临床医学 | 22688篇 |
内科学 | 33099篇 |
皮肤病学 | 2712篇 |
神经病学 | 12660篇 |
特种医学 | 4133篇 |
外国民族医学 | 8篇 |
外科学 | 16069篇 |
综合类 | 29318篇 |
现状与发展 | 30篇 |
一般理论 | 1篇 |
预防医学 | 11114篇 |
眼科学 | 2718篇 |
药学 | 13023篇 |
150篇 | |
中国医学 | 14099篇 |
肿瘤学 | 4311篇 |
出版年
2024年 | 371篇 |
2023年 | 3115篇 |
2022年 | 4676篇 |
2021年 | 8709篇 |
2020年 | 7998篇 |
2019年 | 6416篇 |
2018年 | 6285篇 |
2017年 | 6652篇 |
2016年 | 7161篇 |
2015年 | 6758篇 |
2014年 | 12594篇 |
2013年 | 13424篇 |
2012年 | 10713篇 |
2011年 | 12068篇 |
2010年 | 9420篇 |
2009年 | 8887篇 |
2008年 | 8631篇 |
2007年 | 8925篇 |
2006年 | 8113篇 |
2005年 | 6871篇 |
2004年 | 5761篇 |
2003年 | 5061篇 |
2002年 | 3765篇 |
2001年 | 3399篇 |
2000年 | 2910篇 |
1999年 | 2584篇 |
1998年 | 2206篇 |
1997年 | 2039篇 |
1996年 | 1932篇 |
1995年 | 1815篇 |
1994年 | 1538篇 |
1993年 | 1325篇 |
1992年 | 1240篇 |
1991年 | 962篇 |
1990年 | 841篇 |
1989年 | 756篇 |
1988年 | 747篇 |
1987年 | 655篇 |
1986年 | 579篇 |
1985年 | 798篇 |
1984年 | 607篇 |
1983年 | 392篇 |
1982年 | 485篇 |
1981年 | 436篇 |
1980年 | 339篇 |
1979年 | 286篇 |
1978年 | 198篇 |
1977年 | 152篇 |
1976年 | 128篇 |
1975年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
《Journal of PeriAnesthesia Nursing》2020,35(2):125-134
PurposeThis article reviews state of the science of preoperative risk factors associated with postanesthesia care unit (PACU) pediatric respiratory complications.DesignAn integrative review.MethodsA search of PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), MEDLINE, Scopus, Cochrane, and Joanna Briggs Institute databases was performed. Thirty-one articles, published between 2006 and 2018, were appraised for quality and the level of evidence using the Johns Hopkins Nursing Evidence-Based Practice Model.FindingsThese articles were grouped into the following categories: age, American Society of Anesthesiologists status, gender, airway comorbidities, syndromes, anomalies, pulmonary comorbidities, ethnicity, obesity, neurologic comorbidities, and cardiac comorbidities.ConclusionsEvidence identified significant preoperative and anesthesia risk factors that are associated with PACU pediatric respiratory complications. This article reveals the importance for the perioperative team to identify, assess for, communicate, and develop a management plan for pediatric respiratory complications. 相似文献
72.
73.
Rafiye Ciftciler Haluk Demiroglu Yahya Buyukasık Elifcan Aladag Salih Aksu Ibrahim C. Haznedaroglu Nilgun Sayınalp Osman Ozcebe Umit Yavuz Malkan Hakan Goker 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):177-182
Background
Refractory acute myeloid leukemia (AML) includes AML includes failure of disease to respond to standard induction chemotherapy, relapse within 6 months after first CR, and 2 or more relapses. The outcome of these patients is usually very poor; only a small proportion can be rescued by allogenic hematopoietic stem-cell transplantation (allo-HSCT). The aim of this study was to evaluate the efficacy and feasibility of allo-HSCT in patients with refractory AML.Patients and Methods
We retrospectively analyzed the clinical outcome of 91 patients who were diagnosed with treatment-refractory AML at Hacettepe University Hospital between January 2002 and June 2018. Patients' disease status included refractory AML, defined as failure to respond to standard induction chemotherapy and relapse within 6 months after first complete remission.Results
The median follow-up was 12 months (range, 0.5-184 months) for the entire group. Kaplan-Meier estimates of the 3-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 67% and 12%, respectively. Additionally, the Kaplan-Meier estimates of 5-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 44% and 4%, respectively (P < .001). Complete remission was obtained in 25 patients (83.3%) who underwent allo-HSCT; however, the disease of only 3 patients (3.8%) exhibited complete response after salvage chemotherapy.Conclusion
Allo-HSCT is still the best-known treatment option with curative potential in patients with treatment-refractory AML. Therefore, all efforts should be made in an attempt to find a suitable matched donor in order to perform allo-HSCT. 相似文献74.
75.
76.
77.
78.
79.
目的:比较经鼻导管高流量吸氧(HFNC)与经鼻气道正压通气(nCPAP)在重症毛细支气管炎呼吸支持中的应用价值,为临床治疗方案的选择提供参考。方法:选取2016年12月至2018年12月我院儿科收治的重症毛细支气管炎患儿90例,采用随机数字表法分为观察组和对照组各45例。两组患儿入院后均给予常规综合治疗以保证呼吸道通畅,在此基础上观察组采用HFNC治疗,对照组采用nCPAP治疗,比较两组患儿治疗前和治疗24 h后呼吸频率、经皮血氧饱和度(TcSO2)、呼吸窘迫评分体系(CSS)评分、动脉血氧分压(PaO2)等呼吸相关指标及治疗前后临床症状体征改善情况。结果:两组患儿治疗24 h后呼吸频率、CSS评分均降低,且观察组降低程度更大,TcSO2、PaO2于治疗24 h后升高,观察组升高幅度较对照组明显;治疗后两组患儿咳嗽及肺部湿啰音、肺部炎症情况均改善,观察组症状体征消失时间早于对照组,差异均有统计学意义(P<0.05)。结论:重症毛细支气管炎患儿采用HFNC治疗可明显改善通气功能和临床症状,治疗效果优于nCPAP治疗,可扩大样本量进一步观察。 相似文献
80.